Wednesday, July 8, 2026

Drug profile · INN

carbachol

carbachol (CARBACHOL) is a muscarinic acetylcholine receptor m3 agonist. Route of administration: intraocular. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — carbachol
US status
approved
Class
Route
INTRAOCULAR
Patents
0
Programs
0
Data quality
0.84

Quick answer

carbachol (CARBACHOL) is a muscarinic acetylcholine receptor m3 agonist. Route of administration: intraocular. Current US regulatory status: approved.

Key facts

INN carbachol
Brand CARBACHOL
Mechanism Muscarinic acetylcholine receptor M3 agonist
Target Muscarinic acetylcholine receptor M3
Route INTRAOCULAR
Formulation SOLUTION

Mechanism of action

Muscarinic acetylcholine receptor M3 agonist

Primary target: Muscarinic acetylcholine receptor M3

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. ipratropium bromide Muscarinic acetylcholine receptor M3 antagonist
  2. acetylcholine chloride Muscarinic acetylcholine receptor M3 agonist
  3. aclidinium bromide Respiratory system (R03)
  4. cyclopentolate hydrochloride Muscarinic acetylcholine receptor M3 antagonist
  5. methacholine chloride Muscarinic acetylcholine receptor M3 agonist
  6. revefenacin Muscarinic acetylcholine receptor M3 antagonist

Frequently asked questions

What is carbachol?

carbachol (CARBACHOL) is a muscarinic acetylcholine receptor m3 agonist. Route of administration: intraocular. Current US regulatory status: approved.

What is the brand name for carbachol?

CARBACHOL is a marketed brand name for carbachol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of carbachol?

carbachol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.